Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $6.08 and traded as low as $4.37. Mannatech shares last traded at $4.58, with a volume of 11,133 shares traded.
Wall Street Analyst Weigh In
Separately, Weiss Ratings lowered shares of Mannatech from a “sell (d-)” rating to a “sell (e+)” rating in a report on Friday, July 17th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on Mannatech
Mannatech Stock Up 6.4%
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The company had revenue of $24.92 million during the quarter.
Insiders Place Their Bets
In related news, Director Kevin Andrew Robbins purchased 7,100 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was purchased at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the acquisition, the director owned 33,333 shares in the company, valued at approximately $138,998.61. This trade represents a 27.07% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last three months, insiders have acquired 14,903 shares of company stock worth $62,155. 47.50% of the stock is currently owned by corporate insiders.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Stories
- Five stocks we like better than Mannatech
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
